The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The gastric volvulus treatment market is witnessing significant growth driven by the rising geriatric population.

• Older adults over 65 years are prone to various diseases, including gastric volvulus.
• In 2021, the United States had over 55.8 million people aged 65 and above, constituting nearly 16.8% of the total population.
• Major players include PAI Pharma, Sun Pharmaceutical Industries Ltd., Pfizer Inc., and GlaxoSmithKline PLC.

Product Innovation In Gastric Volvulus Treatment Market
Product innovation is a key trend driving the gastric volvulus treatment market.

• Pfizer Inc. introduced VELSIPITY (etrasimod), an oral sphingosine-1-phosphate (S1P) receptor activator for moderate to severe active ulcerative colitis.
• Pfizer’s acquisition of Arena Pharmaceuticals for $6.7 billion bolsters expertise in inflammation and immunology, expanding therapeutic options.
• Companies strive to develop novel therapies and improve patient outcomes.

Market Segmentation and Treatment Trends
The gastric volvulus treatment market offers various treatment options and routes of administration.

1. By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus.
2. By Treatment Type: Medication, Surgery.
3. By Route of Administration: Oral, Parenteral.
4. By Distribution Channel: Hospital Pharmacy, Retail Pharmacy.
5. By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users.

Regional Insights: North America Leads, Asia-Pacific Emerges
North America dominates the gastric volvulus treatment market, with Asia-Pacific emerging as the fastest-growing region.

• North America’s robust healthcare infrastructure and high prevalence of gastric volvulus contribute to market dominance.
• Asia-Pacific’s growth is fueled by rising healthcare expenditure and increasing awareness of gastrointestinal disorders.

Future Outlook and Conclusion
The gastric volvulus treatment market is poised for substantial growth.

• Regulatory changes, innovations in surgical procedures, and a growing geriatric population are key drivers.
• Minimally invasive surgical techniques and personalized treatment plans enhance patient care.
• Collaboration among medical practitioners and customized treatment approaches optimize outcomes.
• With North America leading and Asia-Pacific rapidly growing, the market is projected to reach $34.63 billion by 2028.
• As the global population ages and healthcare technologies evolve, the demand for effective gastric volvulus treatments remains strong, ensuring continued market expansion.

View More On The Gastric Volvulus Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Request A Sample Of The Global Gastric Volvulus Treatment Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=9382&type=smp